13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-13, with 33 holding rows worth $312,194,442.
- Accession
- 0000945621-25-000464
- Filer
- CIK 1475373
- Filed
- 2025-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 33 entries on the cover page, a total value of $312,194,442 stated on the cover page (in dollars after the unit check, H1), rows summing to $312,194,442 with VALUE read as dollars as filed, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 435,000 | $26,530,650 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 925,000 | $23,439,500 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 82,000 | $18,782,920 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 205,000 | $18,421,300 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 59,000 | $18,381,450 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 98,000 | $16,252,320 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 140,000 | $15,687,000 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 202,000 | $13,685,500 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 113,631 | $12,860,757 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 28,779 | $12,517,714 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 88,000 | $12,123,760 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 177,000 | $10,745,670 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 137,348 | $9,709,130 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 159,000 | $9,627,450 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 123,000 | $8,915,040 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 211,970 | $8,847,628 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 285,842 | $8,623,853 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 247,650 | $8,477,060 | dollars as filed | |
| QIAGEN NV | N72482206 | COM SHS | 187,000 | $7,508,050 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 25,000 | $6,615,000 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 43,000 | $5,783,500 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 477,073 | $5,009,267 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 62,000 | $5,004,020 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 92,250 | $4,701,060 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 180,523 | $3,458,821 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 13,829 | $3,368,191 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 30,000 | $2,731,800 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 17,000 | $2,649,620 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 18,639 | $2,550,561 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 25,000 | $2,440,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 35,000 | $2,296,000 | dollars as filed | |
| SOLVENTUM CORP COM SHS | 83444M101 | Stock | 30,000 | $2,281,200 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 55,000 | $2,168,650 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000945621-25-000464 | this filing | 2025-05-13 | acceptance time not in the bulk data set |